TransCode Therapeutics Inc (RNAZ)

[tapioca]

Down 50% and not done, bottomless pit..

[chumfm]

They wanted the RS from the beginning.Doesn't make sense,if your over a dollar, then you meet the requirements.If you need to do a RS to be over a dollar to meet the requirements.The difference is the dilution that follows.It's the fees and the transaction itself that make the insiders money.They don't care about the common shareholder,they are just the grease.All these stocks do these RS's to line their pockets.There has been more RS's this year,and it's only May,than in any other year.All these companies are doing the same things and the same capital groups are funding the RS's.Aegis Capital comes to mine.Read the paperwork people,because it's your money.Good luck and good trading.

[ttottip]

A bounce back after such a huge drop ? It happens often.

[tapioca]

Idiots announce an upcoming vote on a r/s when the stock was finally moving and trading up near $2 and now it tanks, . Unreal

[ttottip]

What a disaster here!

[tapioca]

Congrats to those who sold at $2, didn’t think we’d see these levels again.. wow

[tapioca]

~~~

[Tiger Money]

Too funny. Thanks!

[dinogreeves]

Always ask yourself, if the company has a great science behind their technology, then why do an offering below 1.50. This is heading for a reverse split for sure, then another good round of dilution.

[MetaMonster]

Shorts out of ammo?? Burn in hell

[MetaMonster]

Is that all you got dirty rat shorts??now get ready to burn in hell$

[tapioca]

No but we’ve left correction territory and entered dump city…

[Tiger Money]

Any color behind this move down? Thanks

[Money hunt]

I smell news in the air dudes!!!!

[tapioca]

Early morning selloff to the low 1.20’s, let’s see if it holds up today..

[Tahoe2468]

bio chart seems to be stabilized here and looks like flow is going upwards right now has 6.5m float , 2.5 months of cash and warrants at $1.22 company also had FDA clearance news earlier this month and Phase 1 trials expected to commence any day now ( Q2 2024 ) and also had $3 price target out this month as well. healthcare sector penny at same price range as ACON and known runner

[MetaMonster]

HELL IS WHERE THE SHORTS BELONG FOR SUPPRESSING NEW HOPE FOR TERMINALLY ILL CANCER PATIENTS

[MetaMonster]

TAKE OUT THE BREAKTHROUGH NEWS AND SHOCK THE WORLD

[MetaMonster]

NEW HOPE TTX-MC138 DESERVES THE WORLDS ATTENTION FOR THE TERMINALLY ILL CANCER PATIENTS

[MetaMonster]

HAIL THE HOLY GRAIL IN CANCER RESEARCH

[MetaMonster]

Tomorrow is The Stars and Stripes", "Old Glory", Star-Spangled Banner" RnA Breakthrough Made in the USA

[Monksdream]

RNAZ tomorrow is another day to see if the mark up campaign can continue

[MetaMonster]

It's a full fledged war to get TTX-MC138, to the terminally ill cancer patients, we are about to witness Transcode therapeutics true power of hard work and dedication.

[Money hunt]

Blast out the news, Let’s rock and roll$$

[Tahoe2468]

Then I will kiss your feet… lol

[MetaMonster]

What if TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and other get partnership agreement with a giant Pharma

[MetaMonster]

What if TTX-MC138 gets fast track status from FDA for terminally ill cancer patients with no hope , Keep in mind they tested it already on one patient and results can follow next week

[Tahoe2468]

It will test $2 next week

[Tahoe2468]

This is how I understand the proposal 4 [to grant the Board the authority to file an amendment to effect the reverse spilt in their discretion before Dec 31, 2024] see page 21-28 https://ir.transcodetherapeutics.com/static-files/2eab1bdd-3a8d-46a1-a1ad-8dfe8aa1770b 1. The primary reason for rs is to increase the stock price for the purpose of regaining $1 minimum bid requirement & raise investor interest (explained on page 22, see screen shot) 2. When the proxy material was written, the stock price was around $0.45, and the company needed a plan to increase the stock price when they appeal the decision to delist in the Hearing panel on May 14, imo. 3. On page 26, it states "The Reverse Stock Split will not be consummated, if at all, until after approval of our stockholders is obtained." So proposal 4 is to grant the Board authority to decide if R/S is needed, and if they deem so, there will be another vote [similar to last time]. Otherwise, if R/S not needed, such authority will expire by Dec 31, 2024 $RNAZ

[MetaMonster]

Mark my words RNAZ'S TTX-MC138 Is the most undervalued company in all Nasdaq, It could be the next HOLO Move

[MetaMonster]

This breakthrough RNA treatment has been suppressed for so long that shorts deserve to burn in hell once and for all, God bless RNAZ

[Tahoe2468]

Wait till the herd gets wind of this… I’m always early for a reason but 3 days is when it goes ballistic after buy in… this weekend should have more eyeballs on this. Thanks for the stock tip found this one from you on HOLO forum.. that one hits $1.50 or less it’s a buy!

[MetaMonster]

Still way undervalued here, MARKET CAP
$9.26M
SHARES OUTSTANDING
6.57M
PUBLIC FLOAT
6.54M

[Tahoe2468]

Trend is our friend

[MetaMonster]

New hope TTX-MC138 in Patients with Advanced Solid Tumors

[Tahoe2468]

All signs still pointing to get to about $3. After that well that’s crazy if it does

[MetaMonster]

The time has come to declare The Stars and Stripes", "Old Glory", Star-Spangled Banner breakthrough for the terminally ill cancer patients

[misterfishman]

I admit I did that.sold under 2 and bought back in.

[Ms Labonte]

I want to party $weet$$$ pop pill$ and fly

[Tahoe2468]

Dear TransCode Stockholder:
I am pleased to invite you to attend the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of TransCode Therapeutics, Inc (the “Company” or “TransCode”). The Annual Meeting will be held on June 13, 2024, at 9:30 a.m., local time, at the offices of Goodwin Procter LLP, 100 Northern Avenue, Boston, MA 02210.
We intend to hold our Annual Meeting in person. In the event it is not possible or advisable to hold our Annual Meeting in person, we will announce alternative arrangements for the meeting as promptly as practicable, which may include holding the meeting solely by means of remote communication. Please monitor our annual meeting website at https://ir.transcodetherapeutics.com/annual-meeting for updated information. If you are planning to attend our Annual Meeting, please check the website one week prior to the meeting date. To ensure that your vote is counted, we encourage you to vote your shares by proxy prior to the Annual Meeting. If you decide to change your vote or if you are a stockholder of record and decide to vote in person at the Annual Meeting, your updated vote will be the vote that is counted.
At this Annual Meeting, the agenda includes:
•
election of four (4) directors, Philippe P. Calais, PharmD, PhD, Thomas A. Fitzgerald, Erik Manting, PhD, and Magda Marquet, PhD, for one-year terms until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal;
?
•
approval of an amendment to the Company’s 2021 Stock Option and Incentive Plan to increase the number of shares available for issuance thereunder by 3,000,000 shares, as more fully described in this Proxy Statement (as defined below);
?
?
•
ratification of the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024;
?
?
•
approval of an amendment to our amended and restated certificate of incorporation, as amended (the “Charter”), to authorize our Board of Directors, or Board, if they determine that doing so is in the best interest of our shareholders, to effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”), at a ratio, ranging from one-for-two (1:2) to one-for-forty (1:40), with the exact ratio to be set within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders;
?
?
•
approval of a proposal to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the amendment to the Company’s 2021 Stock Option and Incentive Plan proposal and the reverse stock split proposal; and
?
•
the transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
?
This 2024 Annual Meeting Proxy Statement (the “Proxy Statement”) and enclosed proxy card are first being mailed to stockholders on or about May???, 2024.
Details regarding admission to the Annual Meeting and the business to be conducted are more fully described in the accompanying Notice of 2024 Annual Meeting of Stockholders (the “Notice”) and the Proxy Statement. Stockholders of record are owners of our stock as of April 22, 2024, and are entitled to vote at our Annual Meeting and any adjournments thereof.

[Tahoe2468]

Read this maybe I’m wrong but it looks like RS and adding shares???


https://fintel.io/sf/us/rnaz

[Tahoe2468]

How many people I’m guessing bought under $1.36 ran it up $2 sold and going to buy back in knowing there are so many bag holders or long term investors now above $1.36. This should go nuts again next week waaaay above $2.00. It corrected the same day it shot up. If it recovers Monday Tuesday dip Wednesday up Thursday Friday should be a killer week

[MetaMonster]

Yo G' Management want to meet up in with shareholders in person this year, must have something exciting in the pipeline,
Dear TransCode Stockholder:
I am pleased to invite you to attend the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of TransCode Therapeutics, Inc (the “Company” or “TransCode”). The Annual Meeting will be held on June 13, 2024, at 9:30 a.m., local time, at the offices of Goodwin Procter LLP, 100 Northern Avenue, Boston, MA 02210.
We intend to hold our Annual Meeting in person. In the event it is not possible or advisable to hold our Annual Meeting in person, we will announce alternative arrangements for the meeting as promptly as practicable, which may include holding the meeting solely by means of remote communication. Please monitor our annual meeting website at https://ir.transcodetherapeutics.com/annual-meeting for updated information. If you are planning to attend our Annual Meeting, please check the website one week prior to the meeting date. To ensure that your vote is counted, we encourage you to vote your shares by proxy prior to the Annual Meeting. If you decide to change your vote or if you are a stockholder of record and decide to vote in person at the Annual Meeting, your updated vote will be the vote that is counted

[Tahoe2468]

AI DON’T LIE…

https://coincodex.com/stock/RNAZ/price-prediction/

[MetaMonster]

RNAZ MOASS Up ahead

[Tahoe2468]

Look at the Green and volume! Anyone over $1.36 is a bag holder and won’t sell or buy more this bad boy is not done….

[MetaMonster]

Exactly 💯

[Tahoe2468]

shares rolling into Class A combo out there now. CUSIP changes, shorts must close and no matter how much they try to hide their shorts, they go onto and remain on their books. They must close.. they'll try fuckery but they can't get the shares off their books without closing them.

[MetaMonster]

Shorts need to be very carefully here, they are going to end up in hell where they belong once and for all

[Tahoe2468]

squeezes come after an exhaustion of selling pressure. This exhaustion can be sudden of gradual and that is the difficulty.

A better way to look at it is wait for it to happen and then cover in earnest at market. You will have bad execution, but think of the “smart money” dudes who decided to hold on and got squeezed